Renaissance Technologies’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-433,100
Closed -$82K 4080
2024
Q1
$82K Sell
433,100
-33,500
-7% -$7.61K ﹤0.01% 3404
2023
Q4
$76K Buy
466,600
+142,800
+44% +$47.4K ﹤0.01% 3373
2023
Q3
$143K Sell
323,800
-61,100
-16% -$27.9K ﹤0.01% 3168
2023
Q2
$142K Buy
384,900
+177,800
+86% +$152K ﹤0.01% 3386
2023
Q1
$377K Sell
207,100
-1,000
-0.5% -$2.17K ﹤0.01% 3013
2022
Q4
$431K Buy
208,100
+7,500
+4% +$23.7K ﹤0.01% 3032
2022
Q3
$604K Buy
200,600
+31,318
+19% +$111K ﹤0.01% 2813
2022
Q2
$542K Buy
+169,282
New +$917K ﹤0.01% 3119

Other funds holding HLTH

Renaissance Technologies's HLTH Position: Q2 2024 in Review

Renaissance Technologies sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 433,100 shares — an estimated $82K sold.

Renaissance Technologies first reported a position in HLTH in Q2 2022 and held it in 8 quarters. The position peaked at $604K in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Renaissance Technologies reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 433,100 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $82K.
  • Renaissance Technologies first reported a position in Cue Health Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Renaissance Technologies's Cue Health Inc. Common Stock position peaked at $604K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.